Kagocel 12 mg tablets 10
Women's clothing size
With your arms relaxed at your sides, measure around the fullest part of your chest.
Measure around the narrowest part of your natural waist, generally around the belly button. To ensure a comfortable fit, keep one finger between the measuring tape and your body.
Active substance: kagocel 12 mg.
Excipients: potato starch - 10 mg, calcium stearate - 0.65 mg, Ludipress (composition: lactose monohydrate - from 91% to 95%, povidone (Collidon 30) - from 3% to 4%, crospovidone (Collidon CL) - from 3% to 4%) - until a tablet weighing 100 mg is obtained.
The active substance is the sodium salt of the copolymer (1→4)-6-0-carboxymethyl-β-D-glucose,(1→4)-β-D-glucose and (21→24)-2,3,14,15,21,24,29,32-octahydroxy-23-(carboxymethoxymethyl)-7,10-dimethyl-4,13-di(2-propyl)-19,22,26,30,31-pentaoxaheptacyclo [18.104.22.168 16.20 .0 5.28 .0 8.27 .0 9.18 .0 12.17 ] dotriakonta-1,3,5(28),6,8(27),9(18),10,12(17),13,15-decaens.
Causes formation in the human body of the so-called late interferons, which are a mixture of alpha and beta interferons with high antiviral activity. Kagocel ® causes the production of interferons in almost all populations of cells participating in the antiviral response of the body: T- and B-lymphocytes, macrophages, granulocytes, fibroblasts, endothelial cells. When ingestion of one dose of Kagocel ® the titer of interferons in the blood serum reaches maximum values after 48 h. The interferon response of the body to the introduction of kagocel is characterized by prolonged (up to 4-5 days) circulation of interferons in the bloodstream. The dynamics of the accumulation of interferons in the intestine when taking the drug inside does not coincide with the dynamics of the titers of circulating interferons. In the blood serum, the production of interferons reaches high values only 48 hours after taking kagocel, while in the intestine the maximum production of interferons is noted. after 4 hours.
Preparation Kagocel ® when administered in therapeutic doses, it is non-toxic, does not accumulate in the body. The drug does not have mutagenic and teratogenic properties, is not carcinogenic and does not have an embryotoxic effect.
The greatest effectiveness in the treatment of Kagocel ® is achieved when it is prescribed no later than the 4th day from the onset of acute infection. For prophylactic purposes, the drug can be used at any time, incl. and immediately after contact with the causative agent of infection.
Indications for use
- prevention and treatment of influenza and other acute respiratory viral infections in adults and children aged 3 years and older;
- treatment of herpes in adults.
- lactation (breastfeeding);
- children's age up to 3 years;
- lactase deficiency, lactose intolerance, glucose-galactose malabsorption;
- hypersensitivity to the components of the drug.
Use in pregnancy and lactation
Due to the lack of necessary clinical data, the drug is contraindicated for use during pregnancy and lactation (breastfeeding).
Use in children
Contraindicated in children under 3 years of age.
To achieve a therapeutic effect, taking the drug Kagocel ® should be started no later than the 4th day from the onset of the disease.
Influence on the ability to drive vehicles and control mechanisms
The effect of the drug on the ability to drive vehicles, mechanisms have not been studied.
Preparation Kagocel ® combines well with other antiviral drugs, immunomodulators and antibiotics (additive effect).
Dosage and Administration
The drug is taken orally, regardless of food intake.
Adults for the treatment of influenza and ARVI are prescribed in the first 2 days - 2 tabs. 3 times / day, in the next 2 days - 1 tab. 3 times / day. Total for a course of 4 days - 18 tab.
Prevention of influenza and ARVI is carried out in 7-day cycles: 2 days - 2 tab. 1 time / day, break for 5 days. Then the cycle is repeated. The duration of the prophylactic course is from 1 week to several months.
For the treatment of herpes, 2 tabs are prescribed. 3 times / day for 5 days. Total for a course lasting 5 days - 30 tab.
Children aged 3 to 6 years for the treatment of influenza and ARVI are prescribed in the first 2 days - 1 tab. 2 times / day, in the next 2 days - 1 tab. 1 time/day. Total for a course of 4 days - 6 tab.
Children aged 6 years and older for the treatment of influenza and ARVI are prescribed in the first 2 days - 1 tab. 3 times / day, in the next 2 days - 1 tab. 2 times/day. Total for a 4-day course - 10 tab.
In children aged 3 years and older, the prevention of influenza and ARVI is carried out in 7-day cycles: 2 days - 1 tab. 1 time / day, a break for 5 days, then the cycle is repeated. The duration of the prophylactic course is from 1 week to several months.
Treatment: in case of accidental overdose, it is recommended to prescribe a plentiful drink, induce vomiting.
Possible: allergic reactions.
If any of these side effects are aggravated, or the patient notices any other side effects, he should inform the doctor about it.
The drug should be stored out of the reach of children, protected from light at a temperature not exceeding 25 ° C.
Shelf life - 4 years.
- Nearmedic Pharma
- Dosage form
- 12 mg
- Number of tablets
- INN Russian